New Jersey, which has seen a 25 percent increase in new cases, compared with the average two weeks earlier, also announced vaccine eligibility would expand beginning on April 5 for residents 55 and older.

The state is expecting more doses delivered in the coming weeks.

But Minnesota’s health department said there would not be enough vaccines on Tuesday to meet the immediate demand. Kansas, Minnesota and South Carolina announced on Friday that they would open vaccine eligibility to residents 16 years and older next week. States are racing to vaccinate as many people as possible as the United States’ coronavirus infection curve continues its plateau for a third week at more than 55,000 new cases per day, a level that health experts warn could rapidly escalate into a new wave. Ursula von der Leyen, president of the European Commission, posted on Twitter on Thursday that the European Union had shipped out 77 million doses since early December, that 88 million were expected to be distributed internally by the end of the week and that 62 million shots had been administered within member nations.Ī drive-through inoculation site in Cleveland, Miss., last week. On Wednesday, it revealed emergency legislation that would curb exports of Covid-19 vaccines manufactured in its countries for the next six weeks. The European Union has exported more vaccine doses than it has administered. The shot is more easily stored and less expensive than Pfizer’s or Moderna’s, and for now, it is sold without the goal of earning a profit. Trust in the AstraZeneca vaccine is essential to fighting the pandemic worldwide. The agency said a new warning label would be added to the vaccine so that people in the medical community could watch for rare complications that could lead to blood clots and brain bleeds. “If the number of infections rises rapidly at the same time as the vaccination, the risk increases that the next virus mutation will become immune to the vaccine.” “The next few weeks will decide whether we can get the pandemic under control in the foreseeable future,” Helge Braun, an aide to Germany’s chancellor, Angela Merkel, told the German newspaper Bild am Sonntag. The hitches in Europe’s vaccine rollout come as some countries, like Germany, are facing a spike in new cases.

But public confidence in the shot has been severely undermined. Most of those countries have resumed using it, after the E.U. And it has been stymied by supply disruptions and shortages.Įurope also experienced a scare over the safety of the AstraZeneca vaccine and distribution in several countries was temporarily halted. The bloc of 27 nations was comparatively slow to negotiate contracts with drugmakers, and regulators were cautious and deliberative in approving some vaccines. Though the European Union is flush with cash, influence and negotiating heft, only about 10 percent of its citizens have received a first dose, compared with 26 percent in the United States and 44 percent in Britain. The moves could speed up the Continent’s lagging vaccine production and distribution, which have been plagued by delays and setbacks. It also loosened regulations for how long the Pfizer vaccine must be stored at ultralow temperatures. The agency, an arm of the European Union and Europe’s top drug regulator, approved sites in the Netherlands, Germany and Switzerland. The European Union’s stumbling Covid-19 vaccination drive, badly shaken by the recent AstraZeneca safety scare, got a boost Friday from the European Medicines Agency, which approved new AstraZeneca, Pfizer-BioNTech and Moderna vaccine production sites. Only about 10 percent of Europeans have received a first dose. More than two in five American adults reported recent symptoms of an anxiety or depressive disorder.Ī nurse preparing vaccine syringes in Munich last week. Take a look at who has been vaccinated so far in New York City.Įthiopians scramble to secure oxygen for patients as the country’s caseload grows. Kenya imposes sharp restrictions on Nairobi and surrounding counties as a surge builds. The C.D.C.’s ex-director offers no evidence in favoring speculation that the coronavirus originated in a lab. manufacturers hit their stride, vaccine scarcity will soon turn to a glut. Scientists plan to track possible virus spread in vaccinated U.S. approves more vaccine production sites amid lagging inoculation efforts.Īt least 34 states are giving all adults vaccine access by mid-April, and more aim to by Biden’s May 1 goal. Kansas, Minnesota and South Carolina said those 16 years and older would be eligible next week, and New Jersey said people 55 and older would be eligible on April 5. The United States could soon have a glut of vaccine doses.

Mariachi tierra mia reading pa